Publications

From a failed pharmaceutical compound to the backbone of modern agriculture — how glyphosate's unique mechanism, the rise of Roundup Ready GMO crops, and pre-harvest desiccation made it inescapable in the American food supply.

How glyphosate's safety threshold shifted twentyfold in six years, and the disputed mouse-tumor data behind the EPA's swing from "possible carcinogen" to "evidence of non-carcinogenicity."

The IARC's "probably carcinogenic" classification, the EPA's contradicting review, and the Ninth Circuit ruling that vacated it — how two regulators reached opposite conclusions from the same evidence.

From the Johnson verdict and Bayer's multibillion-dollar settlements to the Supreme Court's ruling in Monsanto v. Durnell and the glyphosate executive order — how the litigation reshaped the landscape.

A closing look back at the glyphosate series, comparing how oncology and environmental toxicology each handle evidence, uncertainty, and risk.

A former inoculator's perspective on vaccine history and hesitancy — from Jenner's cowpox experiment to the smallpox eradication campaign to today's mRNA vaccines.

A great-uncle's WWII Air Raid Warden cards prompt a look at how America's fractured, individualistic pandemic response compares to the coordinated home-front effort of the 1940s.